Gaud.Ns
GAUD.NS operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and equipment offerings.
Business. GAUD.NS operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and equipment offerings.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
GAUD.NS operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and equipment offerings.
GAUD.NS maintains a relatively strong liquidity position, with a current ratio of 1.42, indicating that it has sufficient current assets to cover its current liabilities. However, the company's liquidity is assessed as medium, and it has a negative net cash position after subtracting total debt, which could pose a challenge in the short term.
In terms of profitability, GAUD.NS demonstrates a return on equity (ROE) of 41.31% and a return on assets (ROA) of 21.61%, both of which are strong indicators of efficient use of equity and assets to generate profit. These figures suggest that the company is performing well compared to the industry median for healthcare facilities and services, where ROE and ROA are typically lower due to the capital-intensive nature of the sector.
The company's revenue is not segmented by geographic regions or business lines in the provided data, making it difficult to assess the concentration of revenue across different markets or product lines. However, the absence of detailed segment data implies that the company may not have a highly diversified revenue base, which could increase its exposure to regional or market-specific risks.
GAUD.NS has shown a positive growth trajectory, with a strong operating cash flow of INR 87,176,000 and a free cash flow of INR 122,959,000, indicating that the company is generating more cash than it is spending on operations and capital expenditures. The capital expenditure of INR -88,784,000 suggests that the company is investing in its operations, which could support future growth.
The risk assessment for GAUD.NS indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.45 is relatively low, suggesting that it is not overly leveraged. However, the negative net cash position after subtracting total debt is a concern, as it may limit the company's ability to fund operations or investments without external financing.
There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial position. The absence of recent events does not necessarily indicate a lack of activity but may reflect the timing of the data collection.
- GAUD.NS has a strong return on equity and return on assets, indicating efficient use of capital.
- The company's liquidity is assessed as medium, with a current ratio of 1.42.
- GAUD.NS has a negative net cash position after subtracting total debt, which could pose a short-term liquidity challenge.
- The company is generating positive operating and free cash flows, supporting its growth and operational needs.
- The absence of detailed segment data suggests a potential lack of revenue diversification.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- GAUD.NS Market data — financials · 2026-05-28